Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Moghimi

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|September 18, 1989
Differential properties of organ-specific serum opsonins for liver and spleen macrophagesS M Moghimi, H M Patel
Biochimica Et Biophysica Acta|September 18, 1989
Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomesS M Moghimi, H M Patel
Advanced Drug Delivery Reviews|July 13, 2011
Complement monitoring of nanomedicines and implantsS M Moghimi, A C Hunter
Advanced Drug Delivery Reviews|April 21, 2019
CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARsF Rahbarizadeh, D Ahmadvand, S M Moghimi
Advanced Drug Delivery Reviews|March 4, 2000
Recent advances in cellular, sub-cellular and molecular targetingS M Moghimi, A R Rajabi-Siahboomi
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1990
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrowS M Moghimi, L Illum, S S Davis
FEBS Letters|July 16, 2003
Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908S M Moghimi, K D Pavey, A C Hunter
FEBS Letters|December 17, 2002
PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performanceJ K Gbadamosi, A C Hunter, S M Moghimi
Pharmacological Reviews|May 18, 2001
Long-circulating and target-specific nanoparticles: theory to practiceS M Moghimi, A C Hunter, J C Murray
Annual Review of Pharmacology and Toxicology|November 1, 2011
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspectiveS M Moghimi, A C Hunter, T L Andresen
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|September 18, 1989
Differential properties of organ-specific serum opsonins for liver and spleen macrophagesS M Moghimi, H M Patel
Biochimica Et Biophysica Acta|September 18, 1989
Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomesS M Moghimi, H M Patel
Advanced Drug Delivery Reviews|July 13, 2011
Complement monitoring of nanomedicines and implantsS M Moghimi, A C Hunter
Advanced Drug Delivery Reviews|April 21, 2019
CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARsF Rahbarizadeh, D Ahmadvand, S M Moghimi
Advanced Drug Delivery Reviews|March 4, 2000
Recent advances in cellular, sub-cellular and molecular targetingS M Moghimi, A R Rajabi-Siahboomi
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1990
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrowS M Moghimi, L Illum, S S Davis
FEBS Letters|July 16, 2003
Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908S M Moghimi, K D Pavey, A C Hunter
FEBS Letters|December 17, 2002
PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performanceJ K Gbadamosi, A C Hunter, S M Moghimi
Pharmacological Reviews|May 18, 2001
Long-circulating and target-specific nanoparticles: theory to practiceS M Moghimi, A C Hunter, J C Murray
Annual Review of Pharmacology and Toxicology|November 1, 2011
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspectiveS M Moghimi, A C Hunter, T L Andresen
Pageof 6